Ali Tavassoli

Chief Scientific Officer

Ali is Professor of Chemical Biology at the School of Chemistry, and Chief Scientific Officer of Curve Therapeutics, a spin-out company from the Tavassoli lab. Ali leads an interdisciplinary team of scientists whose efforts are focused on the development of novel chemical tools that enable new insight into the role of protein-protein interactions in cell biology, and as the starting point for new therapeutics. Ali is president of the Royal Society of Chemistry's (RSC) chemical Biology Interface Division (2020-2023), and a Fellow of the RSC. Ali is on the editorial board of RSC Chemical Biology. Ali was Chair of the RSC's Chemical Biology and Bioorganic Group (2012-2015), and an elected member of the RSC's Chemistry and Biology Interface Division council (2012-2016).

Talks About
#chemistry #biochemistry

Preferred Locations
#NorthAmerica